Post a Comment Print Share on Facebook
Featured Hot News


Test promising for a drug cancer against Parkinson's
the ROME - A drug used against cancer, it promises to be effective in the treatment of Parkinson's disease after a clinical trial phase II, the results of which have appeared in the journal Jama Neurology. The drug, Nilotinib, has been tested on 75 patients and has been shown not only to be safe and well tolerated but also significantly decrease the toxic proteins in the brain typical of the disease (Tau and Alpha-synuclein), then reduce the neurotoxicity and, finally, to slow the decline of motor skills and not of patients, improving the quality of life. The drug has been tested in two different doses and compared to a placebo.

"We have seen that the patients who have taken the nilotinib little better results on the tests of motor skills and reported a better quality of life than patients in the placebo group," explains Fernando Pagan , the main author of the work for you." These are important observations that suggest that nilotinib is able to stabilize the disease, a potential effect of the so-called 'modifier' in the course of the disease, which has never been observed with any other agent with pharmacological", he concludes.

"The Republic will fight always in defense of the freedom of information, to its readers and to all those who have at heart the principles of democracy and civil coexistence"

Carlo Verdelli SUBSCRIBERS TO REPUBLIC © Reproduction reserved Today on Gualtieri: "the presence of The State in the economy should not be taboo. It also serves to improve the functioning of the market" Government, now the Country deserves more in The line of the Highways don't Count. “Review of the concessions is the right of the government,” The company closes in the fort: “We are ready to defend ourselves” “Rates went up much more than inflation”
the Republic
Your Name
Post a Comment
Characters Left:
Your comment has been forwarded to the administrator for approval.×
Warning! Will constitute a criminal offense, illegal, threatening, offensive, insulting and swearing, derogatory, defamatory, vulgar, pornographic, indecent, personality rights, damaging or similar nature in the nature of all kinds of financial content, legal, criminal and administrative responsibility for the content of the sender member / members are belong.